187 related articles for article (PubMed ID: 31216771)
1. Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson's Disease Agents.
Di Stefano A; Marinelli L; Eusepi P; Ciulla M; Fulle S; Di Filippo ES; Magliulo L; Di Biase G; Cacciatore I
Biomolecules; 2019 Jun; 9(6):. PubMed ID: 31216771
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of levodopa and carbidopa antioxidant activity in normal human lymphocytes in vitro: implication for oxidative stress in Parkinson's disease.
Colamartino M; Santoro M; Duranti G; Sabatini S; Ceci R; Testa A; Padua L; Cozzi R
Neurotox Res; 2015 Feb; 27(2):106-17. PubMed ID: 25355370
[TBL] [Abstract][Full Text] [Related]
3. Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease.
Shim JS; Kim HG; Ju MS; Choi JG; Jeong SY; Oh MS
J Ethnopharmacol; 2009 Nov; 126(2):361-5. PubMed ID: 19703534
[TBL] [Abstract][Full Text] [Related]
4. Current Advances in L-DOPA and DOPA-Peptidomimetics: Chemistry, Applications and Biological Activity.
Bizzarri BM; Tortolini S; Rotelli L; Botta G; Saladino R
Curr Med Chem; 2015; 22(36):4138-65. PubMed ID: 26112144
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease.
Kostrzewa RM; Kostrzewa JP; Brus R
Amino Acids; 2002; 23(1-3):57-63. PubMed ID: 12373519
[TBL] [Abstract][Full Text] [Related]
6. Novel imine antioxidants at low nanomolar concentrations protect dopaminergic cells from oxidative neurotoxicity.
Hajieva P; Mocko JB; Moosmann B; Behl C
J Neurochem; 2009 Jul; 110(1):118-32. PubMed ID: 19486265
[TBL] [Abstract][Full Text] [Related]
7. First dual AK/GSK-3β inhibitors endowed with antioxidant properties as multifunctional, potential neuroprotective agents.
Brogi S; Ramunno A; Savi L; Chemi G; Alfano G; Pecorelli A; Pambianchi E; Galatello P; Compagnoni G; Focher F; Biamonti G; Valacchi G; Butini S; Gemma S; Campiani G; Brindisi M
Eur J Med Chem; 2017 Sep; 138():438-457. PubMed ID: 28689095
[TBL] [Abstract][Full Text] [Related]
8. L-dopa- and dopamine-(R)-alpha-lipoic acid conjugates as multifunctional codrugs with antioxidant properties.
Di Stefano A; Sozio P; Cocco A; Iannitelli A; Santucci E; Costa M; Pecci L; Nasuti C; Cantalamessa F; Pinnen F
J Med Chem; 2006 Feb; 49(4):1486-93. PubMed ID: 16480285
[TBL] [Abstract][Full Text] [Related]
9. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
Youdim MB; Stephenson G; Ben Shachar D
Ann N Y Acad Sci; 2004 Mar; 1012():306-25. PubMed ID: 15105275
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of L-dopa amide derivatives as potential prodrugs for the treatment of Parkinson's disease.
Zhou T; Hider RC; Jenner P; Campbell B; Hobbs CJ; Rose S; Jairaj M; Tayarani-Binazir KA; Syme A
Eur J Med Chem; 2010 Sep; 45(9):4035-42. PubMed ID: 20646792
[TBL] [Abstract][Full Text] [Related]
11. Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease.
Nakajima A; Ohizumi Y
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295812
[TBL] [Abstract][Full Text] [Related]
12. Levodopa-Reduced
Johnson SL; Park HY; DaSilva NA; Vattem DA; Ma H; Seeram NP
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30131460
[No Abstract] [Full Text] [Related]
13. Indolalkylamines derivatives as antioxidant and neuroprotective agents in an experimental model of Parkinson's disease.
Sanz E; Romera M; Bellik L; Marco JI; Unzeta M
Med Sci Monit; 2004 Dec; 10(12):BR477-84. PubMed ID: 15567979
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and study of L-dopa-glutathione codrugs as new anti-Parkinson agents with free radical scavenging properties.
Pinnen F; Cacciatore I; Cornacchia C; Sozio P; Iannitelli A; Costa M; Pecci L; Nasuti C; Cantalamessa F; Di Stefano A
J Med Chem; 2007 May; 50(10):2506-15. PubMed ID: 17451233
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic Neuroprotection with Atremorine in Parkinson´s Disease.
Carrera I; Fernandez-Novoa L; Sampedro C; Tarasov VV; Aliev G; Cacabelos R
Curr Med Chem; 2018; 25(39):5372-5388. PubMed ID: 29637853
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant potential of melatonin enhances the response to L-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian mice.
Zaitone SA; Hammad LN; Farag NE
Pharmacol Rep; 2013; 65(5):1213-26. PubMed ID: 24399717
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
18. New L-dopa codrugs as potential antiparkinson agents.
Sozio P; Iannitelli A; Cerasa LS; Cacciatore I; Cornacchia C; Giorgioni G; Ricciutelli M; Nasuti C; Cantalamessa F; Di Stefano A
Arch Pharm (Weinheim); 2008 Jul; 341(7):412-7. PubMed ID: 18581391
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Effects of Tanshinone I Against 6-OHDA-Induced Oxidative Stress in Cellular and Mouse Model of Parkinson's Disease Through Upregulating Nrf2.
Jing X; Wei X; Ren M; Wang L; Zhang X; Lou H
Neurochem Res; 2016 Apr; 41(4):779-86. PubMed ID: 26537816
[TBL] [Abstract][Full Text] [Related]
20. Microwave-assisted synthesis of hydroxyphenyl nitrones with protective action against oxidative stress.
Chavarría C; Perez DI; Pérez C; Morales Garcia JA; Alonso-Gil S; Pérez-Castillo A; Gil C; Souza JM; Porcal W
Eur J Med Chem; 2012 Dec; 58():44-9. PubMed ID: 23085773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
